|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1212 New York Ave., NW, Suite 800 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1262-12
|
||||||||
|
6. House ID# 305260000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Annetha Hall |
Date | 5/23/2019 1:46:35 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
P.L. 111-375 National Alzheimer's Project Act, All Sections
P.L. 115-119 Recognize, Assist, Include, Support and Engage (RAISE) Family Caregivers Act
P.L. 115-406 Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act
S.591 Guardianship Accountability Act
S.299 Geriatrics Workforce Improvement Act
S.548/H.R.1342 EMPOWER Care Act
H.R.1343 Protecting Married Seniors from Impoverishment Act
S.740 Alzheimer's Caregiver Support Act
H.R. 1955 Study on Use of Anti-Psychotics in Non-nursing Homes
S.880/H.R.1873 Improving HOPE for Alzheimer's Act
H.R.1903/S.901 Younger-Onset Alzheimer's Disease Act of 2019
S.995/H.R.2035 Lifespan Respite Care Reauthorization Act
H.R.647 Palliative Care and Hospice Education and Training Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Centers For Disease Control & Prevention (CDC), Administration on Aging, Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Conant |
|
|
|
Sarah |
Smith |
|
|
|
Jennifer |
Pollack |
|
|
|
Madelyn |
Morrison |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
National Institutes of Health, Alzheimer's Disease, and the Cures Acceleration Network
P.L. 112-25 Budget Control Act of 2011; provisions related to funding for non-defense discretionary programs; entitlements reform
P.L. 114-255 21st Century Cures Act,
P.L. 115-406 Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act
Fiscal Year 2020 Labor, Health and Human Services, Education and Related Agencies Appropriations Bill; all sections related to the National Institutes of Health (NIH), Alzheimer's Disease, and the Cures Acceleration Network
Fiscal Year 2020 Defense Appropriations Bill; Provisions related to the Peer Reviewed Alzheimer's Research Program
Fiscal Year 2020 Interior and Environment Appropriations Bill; provisions related to the Indian Health Service and Alzheimer's disease
Fiscal Year 2020 Agriculture Appropriations Bill; all sections related to the Food and Drug Administration (FDA)
Fiscal Year 2020 Military Construction, Veterans Affairs and Related Agencies Appropriations Bill; provisions related to the Department of Veterans Affairs, specifically Medical and Prosthetic Research and Alzheimer's research
Fiscal Year 2020 Commerce, Justice, Science, and Related Agencies Appropriations Bill; provisions related to grant program established by Kevin and Avonte's Law of 2017
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Defense - Dept of (DOD), Veterans Affairs - Dept of (VA), Interior - Dept of (DOI), Indian Health Service, Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Conant |
|
|
|
Sarah |
Smith |
|
|
|
Jennifer |
Pollack |
|
|
|
Madelyn |
Morrison |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |